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Proteasome inhibitorAAV1 and AAV6 are two closely related AAV serotypes. In the present study, we found AAV6 was more
efﬁcient in transducing mouse lower airway epithelia in vitro and in vivo than AAV1. To further explore the
mechanism of this difference, we found that signiﬁcantly more AAV1 bound to mouse airway epithelia than
AAV6, yet transduction by AAV6 was far superior. Lectin competition assays demonstrated that both AAV1
and AAV6 similarly utilize α-2, 3-, and to a lesser extend α-2, 6- linked sialic acids as the receptors for
transduction. Furthermore, the rates of AAV endocytosis could not account for the transduction differences of
AAV1 and AAV6. Finally, it was revealed that AAV6 was less susceptible to ubiquitin/proteasome-mediated
blocks than AAV1 when transducing mouse airway epithelia. Thus compared with AAV1, AAV6 has a unique
ability to escape proteasome-mediated degradation, which is likely responsible for its higher transduction
efﬁciency in mouse airway epithelium.0730, China.
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AAV is a non-pathogenic human parvovirus with a single-stranded
DNA genome of 4.7 kb encapsidated in an icosahedral protein shell of
~25 nm in diameter (Berns and Giraud, 1996). Following the establish-
ment of the ﬁrst recombinant clone of AAV serotype 2 (AAV2) in 1982
(Samulski et al., 1983), AAV2 vectors have rapidly gained popularity in
gene therapy applications, thanks to their lowpathogenicity, the ability to
transduce non-dividing cells, and the ability to establish long-term
transgene expression. However, clinical applications of AAV vectors
(Berns and Giraud, 1996; Ding et al., 2005; Samulski et al., 1983) have
been impededby its restricted cell/tissue tropism, lowefﬁciencyof in vivo
gene delivery, delayed onset of gene expression, and prevalent pre-
existing neutralizing antibodies in the human populations. Twelve AAV
serotypes –AAV1 through 12 – and over one hundred variants have been
isolated from tissue samples of human, non-human primates, and other
species (Gao,Vandenberghe, andWilson, 2005;Mori et al., 2004; Schmidt
et al., 2008). The tissue tropisms of the different serotypes vary greatly
due to the structural diversity of their capsid proteins. The identiﬁcation
of suitable AAV serotypes for speciﬁc tissues/cell types is highly desirable
and has been pursued intensely in the past decade (Gao, Vandenberghe,andWilson, 2005; Louboutin,Wang, andWilson, 2005).Major efforts are
focused on modifying capsid proteins to improve the transduction
efﬁciency and/or speciﬁcity of AAV-based vectors by rational design and
directed evolution (Asokan et al., 2010; Li et al., 2008; Li et al., 2009). The
design of tissue-targeted capsid constructs will likely expand and
complement the current range of AAV serotypes and variants.
Among all the serotypes, rAAV6 appeared to be a very promising
gene delivery vector for the lung. It was isolated as a contaminant of
an adenovirus type 5 stock and is now believed to be either a variant
of AAV1, with more than 99% amino acid homology between their
capsids (Halbert et al., 2000; Rutledge, Halbert and Russell, 1998), or a
natural recombinant between AAV1 and AAV2 (Xiao et al., 1999). It
was reported that α-2,3 and α-2,6 sialic acids present on N-linked
glycoproteins act as the primary receptors for AAV1 and AAV6 in
multiple cell types by mediating viral attachment and infection (Wu
et al., 2006b). AAV6 vectors have been shown to mediate higher in
vivo transduction in the lung (Halbert, Allen and Miller, 2001),
skeletal muscle(Blankinship et al., 2004), and liver (Wu et al., 2006a)
than AAV2 or AAV1 vectors. Blankinship et al. (2004) reported that
systemic intravenous administration of high dose AAV6 vectors
transduced cardiac and skeletal muscle efﬁciently in mice. Kawamoto
S et al., 2005 demonstrated the signiﬁcant potential of AAV6 serotype
vectors for early gene expression and widespread regional transduc-
tion in myocardium. These results suggest that AAV6 is a promising
vector for gene delivery in vivo. However, the mechanism for the
enhanced transduction of AAV6 in these tissues has not yet been
elucidated.
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of the steps, including the physical binding to the target cells,
receptor-mediated endocytosis, vesicular trafﬁcking, endosomal
escape, and nuclear import, etc. Understanding the key step(s)
hindering AAV transduction will aid in establishing methods to
improve the efﬁciency of rAAV-mediated gene delivery. In the present
study, we have examined these steps in AAV6 mediated transduction
of mouse airway epithelia and have found that AAV6 is gifted with the
unique ability to escape the proteasome degradation pathway, which
is responsible for its superior transduction efﬁciency in mouse
airways.
Results and discussion
AAV6 mediates efﬁcient apical transduction in mouse airway epithelium
in vitro
We have previously reported that the closely related AAV
serotypes AAV1 and AAV6 were able to transduce human airway
epithelial cells (HAE) at higher efﬁciency than other natural serotypes
tested (Li et al., 2009). Here we compared their transduction
efﬁciency on HAE and on differentiated mouse airway epitheliaFig. 1. Transduction efﬁciencies of AAV1 and AAV6 in human and mouse airway epitheli
respectively) were inoculated apically with AAV1-GFP or AAV6-GFP at a dose of 1×1011 v
photomicrographs showing GFP-positive cells were obtained at 14 days post inoculation (p
showing AAV-transduced cells as GFP positive. Cilia were immunolabeled with β-tubulin IV
inoculated with AAV1-GFP or AAV6-GFP (MOI of 5×104). The mRNA from MAE was harvest
qRT-PCR (as described in Material and methods). Asterisk (*) denotes Pb0.01. (D) AAV1-Luc
or the basolateral side of MAE and allowed to incubate at 37 °C for 2 h. At 14 days p.i., lucifer
cm2 epithelia (n=4). RLU, relative light units. Asterisk (*) denotes Pb0.01.(MAE) side by side with AAV1 and AAV6 packaging double strand GFP
(AAV1GFP and AAV6GFP). AAV vectors were inoculated to the apical
surfaces of HAE/MAE at a dose of 1×1011 vg per culture (as optimized
in the previous study), and GFP transgene expressions were
monitored over time. The numbers of GFP-positive cells were found
to reach maximum at 1 week post inoculation (p.i.) and representa-
tive epiﬂuorescence images are shown in Fig. 1A. Consistent with our
previous data, AAV6 showed higher transduction efﬁciency than
AAV1 on HAE. Surprisingly, AAV6 transduced signiﬁcantly more cells
on MAE than on HAE, i.e., about 30–50% for MAE to about 1–2% for
HAE. AAV1 also transduced more cells on MAE (~5%) than on HAE
(b1%), although much less than AAV6. These results suggest that
human and mouse airway epithelia are very different in their
susceptibility to AAV transduction from the apical surface, and that
different AAV vectors may be required for optimal gene transfer in
human or mouse airways. The ﬁnding is consistent with previous
reports that the efﬁciencies of different AAV serotypes on murine
airways were not predictive of their efﬁciencies on human airways
(Flotte et al., 2009; Liu et al., 2006). To determine the cell types
targeted by AAV vectors in MAE, the transduced MAE cultures were
immunolabeled with a cilia speciﬁc marker (β-tubulin IV) followed by
optical x–z confocal microscopy. As shown in Fig. 1B, both AAV1 andal models in vitro. (A) Human and mouse airway epithelial cultures (HAE and MAE
g/culture (1.0 cm2 surface area) (MOI=1×105). Representative en face ﬂuorescence
.i.). (B) Optical x–z confocal images of MAE transduced with AAV1-GFP and AAV6-GFP
antibody (red) as described in Material and methods. (C) The apical surface of MAE was
ed at 1 and 2 months p.i., and relative GFP mRNA copy numbers were determined with
or AAV6-Luc at a dose of 109 gc/culture (1 cm2) was applied to either the apical surface
ase activities were assessed, and presented as the mean (±SEM) luciferase activity per
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ing both ciliated and non-ciliated cells. Although the numbers of cells
transduced by AAV1 and AAV6 were different, their cellular tropism
was similar. In addition, we quantiﬁed the GFP mRNA levels in AAV
transduced MAE by quantitative RT-PCR (Fig. 1C). At one month p.i.,
the GFP mRNA level in AAV6 transduced MAE was approximately one
log higher than that by AAV1, consistent with the GFP ﬂuorescence
data (Fig. 1A). The levels of GFP mRNA at 2 months p.i. were slightly
lower than those at 1 month, conﬁrming that AAV transduction in
MAE is relatively stable.
To validate these resultswithAAVvectors containingdouble strand
GFP transgene, we next tested AAV vectors expressing a single strand
luciferase transgene (AAV1luc and AAV6luc). Both the apical and
basolateral surfaces of MAEwere inoculatedwith AAV1luc or AAV6luc
at 1×109 vg, and luciferase enzyme activities were measured at
2 weeks p.i. (Fig. 1D). Not surprisingly, transductions of both viruses
from the basolateral surface were about 30 fold higher than that from
the apical membrane, even though AAV1 is reported to transduce HAE
from both surfaces equally (Yan et al., 2006). Consistent with the
ﬁndings for GFP-expressing vectors, the transduction efﬁciency of
AAV6 is approximately one Log higher than that of AAV1 from apical
surface, likely due to the increased numbers of cells targeted by AAV6.
AAV6 mediates efﬁcient lumenal transduction in mouse airways and
distal lungs in vivo
To investigate the transduction efﬁciency of AAV1 and AAV6 in
mouse lower airways and distal lungs in vivo, a single dose of 1×1011
vg/mouse of AAV1GFP or AAV6GFP expressing GFP was inoculatedFig. 2. AAV transduction of mouse airways in vivo. (A) Balb/c mice were inoculated by the in
GFP (panels a, b and c) or AAV6-GFP (d, e, and f). Mouse trachea and lungs were harvested
were immunolabeled with rabbit anti-GFP antibody (Sigma) followed by Alexaﬂuor594-co
Representative images for alveolar (a and d), bronchiolus (b and e), and tracheal regions (c
and the mean numbers from ﬁve random images were shown (±SEM).intratracheally in four mice per virus group. Mouse trachea and lungs
were harvested at one month p.i.; tissue sections were immuno-
labeled with GFP speciﬁc antibody to identify AAV transduced cells
(green) with cell nuclei labeled with DAPI (blue). Immunohisto-
chemical analyses of mouse lungs for GFP expression revealed that
these two AAV vectors demonstrated similar targeting patterns of
transduction for conducting airway and alveolar epithelium though
with different degrees of efﬁciency. Representative photomicrographs
of the tracheal, bronchiolus, and alveolar regions were shown in
Fig. 2A. Tissue sections were processed and are representative of four
mice (Fig. 2A). a, b, and c are AAV1mediated GFP expression in alveoli,
bronchiolus, and trachea respectively and d, e, and f are AAV6
mediated GFP expression in alveoli, bronchiolus, and trachea respec-
tively. As shown in Fig. 2B, quantitation of the number of cells of the
alveoli, bronchiolus, trachea expressing GFP indicated that the
transduction efﬁciency of AAV6 and AAV1 of airway epithelia was
signiﬁcantly different. AAV6 appears more efﬁcient than AAV1 in the
airways. Both vectors showed similar efﬁciency in transducing both
alveoli and bronchiolus. In addition, both vectors were detected with
much less frequently in the trachea than in the alveoli and
bronchiolus. However, AAV6 demonstrated higher efﬁciency in the
trachea than AAV1.
Sialic acid mediates AAV1 and 6 transductions in MAE, but cannot
account for the differences in transduction efﬁciencies between AAV1
than AAV6
To elucidate the mechanisms responsible for the different
transduction efﬁciencies between AAV1 and AAV6, we ﬁrsttro-tracheal route with a single dose of 1×1011 vg/mouse in a volume of 50 μl of AAV1-
at 1 month p.i. Parafﬁn-embedded tissue sections were prepared, and transduced cells
njugated goat anti-rabbit antibody (Invitrogen). Nuclei were stained blue with DAPI.
and f) are shown. (B) The numbers of GFP positive cells per image ﬁeld were quantiﬁed
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and MAE cultures. 5×1010 vg/culture (1.0 cm2) of AAV1 or AAV6 was
incubated on the apical surface of HAE orMAE for 2 h at 4 °C. Unbound
viruses were removed followed by three washes with ice-cold DMEM.
The numbers of AAV particles bound to the epithelia were harvested
and quantiﬁed with dot-blot assays (Fig. 3A). Densitometry analysis
(Fig. 3B) revealed that more AAV6 bound to HAE membrane than
AAV1, consistent with the ﬁnding that AAV6 transduced HAE better
than AAV1 (Fig. 1A). However, in contrast to the transduction data,
the binding of AAV1 on MAE was signiﬁcantly more than AAV6 (~3
times more), suggesting that AAV virus binding to target cells (i.e.,
MAE) is not proportional to virus transduction. In another word, the
increased transduction of AAV6 than AAV1 is not due to the increased
vector binding to MAE (the opposite is true). This notion was furtherFig. 3. AAV transductions in HAE/MAE is sialic acid-dependent. (A) Relative AAV bindings to H
to the apical surface of HAE or MAE and incubated at 4°C for 1 h. Cell-associated AAV vir
Densitometry was performed against a standard and results are shown in (B). (C) The apic
lectins: WGA (sialic acids of both α-2,3 and α-2,6 linkages), MAA (α-2,3-linked sialic a
ﬂuorescent photomicrographs were shown. (D) and (E) Lectin competition assay. MAE cultu
The lectins were then removed, and solutions containing 100 μg/ml lectin and AAV1-Luc (D
14 days p.i., and the means (±SEM) were shown (n=4). RLU, relative light units. Asterisksupported by the fact that AAV6 binds both HAE and MAE equally, yet
transduced MAE more than a log better than HAE. Therefore, the
downstream steps must be responsible for the difference in
transduction efﬁciency between AAV1 and AAV6.
Since both AAV1 and AAV6 useα-2,3 andα-2,6 linked sialic acid as
cellular receptors for binding and transduction in non-polarized cells
(Wu et al., 2006b), we examined the types and distributions of sialic
acids on the apical membrane of HAE and MAE using lectin binding
assays. Fluorescence (FITC) labeled sialic acid speciﬁc lectins, namely
wheat germ agglutinin (WGA, recognizes bothα-2,3 and α-2,6 linked
sialic acid), maackia amurensis lectin (MAA, recognizes α-2,3-linked
sialic acid), and sambucus nigra lectin (SNA, recognizes α-2,6-linked
sialic acid) were incubated at 10 μg/ml on the apical surface of HAE
and MAE, followed by three washes with DMEM. Fluorescent lectinsAE andMAE. AAV1 or AAV6 at a dose of 5×1010 vg/culture (cm2) were allowed to bind
al DNA was harvested from cell lysate and quantiﬁed with dot-blot analysis (n=6).
al surface of HAE and MAE was probed with FITC-labeled selective sialic acid-binding
cids), and SNA (α-2,6-linked sialic acids) at 10 μg/ml concentration. Representative
res were pre-incubated on the apical surface with 100 μg/ml of each lectin at 4 °C for 1 h.
) or AAV6-Luc (E) (MOI=2×103) were inoculated. Luciferase assay was performed at
(*) denotes Pb0.05.
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ﬂuorescence microscopy (Fig. 3C). The bindings of WGA on both
HAE and MAE indicated that the apical surfaces of both HAE and MAE
are extensively covered with sialic acid residues. Equal amounts of α-
2,3 and α-2,6 linked sialic acids are present on HAE (MAA and SNA
bindings respectively). However, α-2,3 linked sialic acids appeared to
dominate on MAE, similar to mouse airways in vivo. Taken together
with the AAV virus binding data, we speculate that AAV1 likely binds
toα-2,3 linked sialic acids, however, this interactionmight not lead to
productive transduction.
To determine the roles of sialic acids in AAVmediated transduction
ofMAE,we carried out a lectin competition assay (Figs. 3D, E). AAV-luc
vector (2×109 gc/culture) in the presence of 100 μg/mlWGA,MAA, or
SNA was inoculated on MAE, and AAV transduction was assayed by
measuring luciferase activity at 2 weeks p.i. (Figs. 3D, E). Despite the
difference in AAV1 and AAV6 transductions, the degrees of reductions
in the transduction efﬁciencies by lectin competitions were similar
between AAV1 and AAV6. WGA, which binds to sialic acids of both α-
2,3 and α-2,6 linkages, inhibited approximately 80% of the trans-
ductions for both AAV1 and AAV6, suggesting that AAV1 and 6
transductions on MAE are mostly sialic acid-dependent. MAA (α-2,3-
speciﬁc) blocked ~30% of transduction, whereas SNA (α-2,6-speciﬁc)
only blocked 15% of transduction by both AAV serotypes, likely due to
the fact that there aremoreα-2,3 thanα-2,6 linked sialic acids onMAE
(Fig. 3C). These ﬁndings demonstrate that AAV1 and AAV6 can utilize
both α-2,3 and α-2,6 linked sialic acids as the primary receptors for
MAE transduction, and that sialic acids play a major role in AAV
mediated transduction in the airways for both AAV1 and AAV6
serotypes. Thus, the requirement for sialic acid cannot possibly
account for the differences in transduction efﬁciencies between
AAV1 and AAV6.
Rate of AAV endocytosis cannot account for the differences in the
transduction efﬁciency between AAV1 and AAV6 and between apical vs.
basolateral inoculations
We next compared the rates of AAV internalization in MAE by
measuring the amounts of endocytosed AAV genome numbers using
qPCR of Hirt DNA. MAE were inoculated with equal amounts of AAV1-
luc and AAV6-luc (MOI=1×104) from either the apical or basolateral
side for 2 h followed by three washes with DMEM. Hirt DNA was
extracted at 24 h p.i. and the numbers of endocytosed vector genomes
were quantiﬁed with qPCR (Fig. 4). For both AAV1 and AAV6, thereFig. 4. AAV endocytosis at the apical and basolateral membranes. AAV1 or AAV6 at MOI
of 1×104 was incubated with the apical or basolateral surfaces of MAE cultures at 37 °C
for 2 h, followed by washing with DMEM three times to remove unbound virus. At 22 h
p.i., Hirt DNA was extracted from infected cells and viral genome copies were assessed
by quantitative PCR (qPCR). Data represent the mean±SEM (n=4). Asterisk (*)
denotes Pb0.05.was no difference in endocytosed AAV copies between the apical and
basolateral inoculations, which goes against our previous ﬁnding that
AAV transductions from the basolateral surface were 30-fold higher
than from apical membrane (Fig. 1D). Furthermore, more AAV1
genomes were endocytosed than for AAV6, whereas AAV1 transduc-
tion as measured bymarker gene expressions (i.e., GFP and luciferase)
was at least 10-fold lower than that by AAV6. These ﬁndings suggest
that the difference in AAV vector internalization does not correlate
with viral transduction and cannot account for the higher transduc-
tion efﬁciency of AAV6 than AAV1 or of basolateral than apical
inoculation. Attempts to separate the nuclear and cytoplasmic
fractions of MAE were not successful.AAV6 has a unique ability at escaping the ubiquitin/proteasome
degradation pathway in mouse airway epithelia
The ubiquitin/proteasome pathway plays a role in AAV transduc-
tion of non-polarized cell lines and differentiated human airway
epithelia (Douar et al., 2001; Duan et al., 2000; Yan et al., 2004). Since
neither receptor binding nor vector endocytosis was responsible for
the enhanced AAV6 transduction over AAV1, we investigated the role
of proteasome pathway on AAV1 and AAV6 transductions. Using the
same approach with proteasome modulating agents on HAE (Li et al.,
2009), MAE was inoculated from either the apical or basolateral
surfaces as before with AAV1luc or AAV6luc (MOI=1x103) in the
presence or absence of 40 μM proteasome inhibitor N-acetyl-L-
leucinyl-L-leucinyl-L-norleucinal (LLnL), and the luciferase transgene
expressions were assessed at 2 week p.i. For apical transduction, the
treatment of LLnL signiﬁcantly increased the transduction efﬁciency of
both AAV1 and AAV6 (Fig. 5A). However, AAV1 transduction was
increased by ~5-fold, versus ~2 fold for AAV6. This suggests that AAV6
is less sensitive to proteasomal degradation compared to AAV1. In
another word, AAV6maybe better equipped to escape the proteasome
pathway than AAV1.Fig. 5. Effects of proteasome pathway on AAV transduction of MAE. AAV1-Luc, AAV6-
Luc were inoculated on either the apical surface (A) or the basolateral side (B) of MAE
cultures (MOI=1×103) and incubated for 2 h at 37 °C in the presence or absence of the
proteasome inhibitor LLnL at the concentration of 40 μM. Relative luciferase activities in
relative light units (RLU) were assessed at 2 weeks p.i. Data represent the mean
(±SEM) (n=4). Asterisk (*) denotes Pb0.05.
332 W. Li et al. / Virology 417 (2011) 327–333The same trend holds true for basolateral transduction, except that
it is ~30 fold higher than apical transduction (Fig. 5B). This suggests
that AAV vectors endocytosed from apical or basolateral surfaces were
subjected to a common proteasome processing pathway, and that
both AAV1 and AAV6 were different in their sensitivity to proteasome
degradation. We conclude that AAV6 is unique in its ability to escape
proteasome pathway, which is responsible for its increased trans-
duction efﬁciency in mouse differentiated airway epithelium. None-
theless, there was still signiﬁcant enhancement of AAV6-mediated
expression in the presence of the proteasome inhibitor LnLL,
suggesting that this capsid is not totally resistant. Some or all of the
six amino acid differences between AAV1 and AAV6 capsid may be
responsible for the interaction with the ubiquitin/proteasome factors,
which we are currently investigating.
Material and methods
Viruses and cells
Recombinant AAV vectors containing double stranded GFP (AAV1-
GFP and AAV6-GFP) driven by the chicken-β-actin enhancer and CMV
promoter or single stranded luciferase (AAV1-luc and AAV6-luc) were
produced using the triple plasmid transfection protocol as described
and virus titers were determined by dot-blot analysis (Xiao, Li and
Samulski, 1998). In vitro cultures of differentiated human airway
epithelia (HAE) were generated as described previously(Li et al.,
2009) and cultures of differentiated mouse airway(trachea) epithelial
cells (MAE) were generated as previously described(You et al., 2002).
Transduction of MAE with recombinant AAV vectors
4–6 week-old MAE cultures were inoculated from the apical or
basolateral surface with 100 μl of AAV vectors for 2 h. The MOI varied
from MOI of 1×103 to 1×105, as indicated in the experiments. The
proteasome modulating agent, N-acetyl -L - leucinyl - L - leucinyl- L -
norleucinal (LLnL) (40 μM) (Sigma), was mixed with AAV vectors
before inoculation when noted. Photomicrographs of transduced GFP-
positive cells were acquired using a Leica Leitz DMIRB inverted
ﬂuorescence microscope equipped with a cooled-color charge-
coupled device digital camera (MicroPublisher; Q-Imaging), and
images of ﬁve random ﬁelds for each MAE culture were captured.
Ciliated cells were immunolabeled with a β-Tubulin IV antibody
(Sigma-Aldrich), followed by AlexaFluor594 conjugated goat anti-
mouse antibody (Invitrogen) as described previously (Zhang et al.,
2005). Optical x–z ﬂuorescent confocal images were obtained using a
Zeiss 510 Meta Laser Scanning Confocal Microscope. In MAE
inoculated with luciferase-expressing AAV vectors, luciferase activi-
ties were measured using a luminometer (Perkin Elmer Life Sciences,
Victor2 1420 Multilabel Counter).
AAV transductions in mouse trachea in vivo
C57BL/6 mice (Jackson Lab.) were anesthetized with isoﬂurane
and inoculated intra-tracheally (i.t.) with 1×1011 vg/mouse AAV1-
GFP or AAV6-GFP in a volume of 50 μl by tracheal instillation. At
30 days p.i., mice were sacriﬁced and systemically perfused with PBS.
Lung and trachea were removed and ﬁxed in 10% neutral buffered
formalin overnight, followed by equilibration in PBS containing 15%
sucrose for 48 h. Fixed tissues were embedded in parafﬁn and tissue
sections (5 μm thickness) were subjected to the immunoﬂuorescence
assay to identify AAV transduced cells, which were immunolabeled
with GFP-speciﬁc antibody (Sigma) followed by AlexaFluor568-
conjugated secondary antibody (red) (Invitrogen), whereas nuclei
were stained blue with DAPI. Photomicrographs of transduced GFP-
positive cells were acquired as described previously.AAV binding assays in vitro
AAV1-luc or AAV6-luc was inoculated to either HAE or MAE on the
apical surface at 5×1010 vg/transwell epithelium (1 cm2 surface area)
at 4 °C for 2 h. Cells were then rinsed 3 times with PBS, and cell-
associated AAV viral DNA was extracted by using DNAeasy kit
(Invitrogen). DNA samples were blotted onto a nylon membrane
(Ambion) and AAV viral DNA was detected with a P32-labeled Luc
DNA probe. Viral genome number were quantitated by dot-blot
analysis (Xiao, Li and Samulski, 1998).
Lectin staining and competition assays
Lectin staining of the apical surface of HAE/MAE was performed by
incubating the cells with10 μg/ml FITC-labeled wheat germ agglutinin
(WGA), maackia amurensis lectin (MAA), or sambucus nigra lectin
(SNA) (Vector Laboratories Inc.). Brieﬂy, cells were chilled to 4 °C, and
10 μg/ml lectin diluted in DMEMwas added to the apical surface of the
epithelial cultures and incubated at 4 °C for 1 h. Cultures were then
rinsed three times with DMEM, and ﬁxed with 4% paraformaldehyde.
Fluorescent photomicrographs of cell-bound lectins were captured
with a ﬂuorescent microscope as described above. Lectin competition
experiments were done by pre-incubating cells with 100 μg/ml of
WGA, MAA, or SNA at 4 °C for 1 h, followed by incubation with AAV6-
luc (2×109 gc/transwell) in the presence of 100 μg/ml respective
lectin at 4 °C for 2 h. Cultures were then rinsed three times with
DMEM at 4 °C for 10 min each. Luc expression was determined two
weeks later with as described previously (Perkin Elmer Life Sciences,
Victor2 1420 Multilabel Counter) (Li et al., 2008).
AAV endocytosis assay
MAE cultures were incubated at the apical or basolateral
membrane with AAV1-GFP or AAV6-GFP at the dose of 1×1010
gc/transwell for 2 h followed by three times of 10 min washing to
remove unbound virus. Cultures were returned to incubator for 22 h
to allow AAV endocytosis. Low molecular weight Hirt DNA was
extracted from infected cells as described previously (Duan et al.,
2000; Yan et al., 2004). The viral genome in the Hirt DNA from
endocytosed AAVwas assessed by quantitative PCR (qPCR) performed
on a LightCycler 480 as previously described (Johnson and Samulski,
2009).
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